Jay Adams, MD
Procedural Dermatology · Carson City, NVNPI 1518923424
Payments from drug & device makers
Across 88 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$340
- Lilly USA, LLC$185
- Regeneron Healthcare Solutions, Inc.$153
- Amgen$136
- LEO Pharma Inc.$133
- Novartis$125
- plus $579 from 16 others
What the payments were for
- Speaking & faculty fees$694%
- Food & beverage$1,58396%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $340 |
| Lilly USA, LLC | 9 | $185 |
| Regeneron Healthcare Solutions, Inc. | 6 | $153 |
| Amgen | 7 | $136 |
| LEO Pharma Inc. | 7 | $133 |
| Novartis | 8 | $125 |
| Genentech USA, Inc. | 6 | $120 |
| Johnson & Johnson | 5 | $76 |
| Sanofi | 2 | $47 |
| Sun Pharmaceutical Industries Inc. | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| DUSA Pharmaceuticals, Inc. | 2 | $38 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Pfizer | 2 | $35 |
| UCB, Inc. | 2 | $34 |
| Incyte Corporation | 2 | $28 |
| Organogenesis Inc. | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $13 |
| Almirall LLC | 1 | $12 |
| Biofrontera Inc. | 1 | $1 |
How this compares
Too few procedural dermatology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 21 | $733 |
| Triamcinolone Acetonide | 22 | $363 |
| Prednisone | 14 | $122 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Carson City
- Whitney HovenicReno$6K
- Dominick AddonizioLas Vegas$138
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.